MULTIR Joint Session with EU-Funded Projects ELMUMY and STEPUPIORS
- Oct 16, 2024
- 1 min read
On October 3, 2024, MULTIR proudly took part in a dynamic joint session alongside fellow EU-funded initiatives, ELMUMY and STEPUPIORS. Organized under the #MissionCancer banner, this collaborative event provided a rich forum for exchanging knowledge, aligning efforts, and accelerating progress in cancer research.
The session focused on sharing innovative approaches across diverse cancer research domains:
MULTIR: Driving research into the prediction and modulation of immune responses in melanoma, lung, and bladder cancers.
STEPUPIORS: Investigating prognostic biomarkers in rectal cancer.
ELMUMY: Exploring the risk factors and health determinants behind the progression of monoclonal gammopathies to multiple myeloma.
Each project presented its unique goals, scientific challenges, and breakthroughs. The exchange of ideas was both insightful and inspiring, reinforcing the value of collaboration in our shared mission to transform cancer care. For MULTIR, this event was a powerful reminder of the strength that lies in uniting diverse expertise toward a common goal.
